107 related articles for article (PubMed ID: 28558926)
21. A cost-effectiveness model of smoking cessation based on a randomised controlled trial of varenicline versus placebo in patients with chronic obstructive pulmonary disease.
Lock K; Wilson K; Murphy D; Riesco JA
Expert Opin Pharmacother; 2011 Dec; 12(17):2613-26. PubMed ID: 22017336
[TBL] [Abstract][Full Text] [Related]
22. [Therapies for smoking cessation (antidepressants, nicotine-replacement and counseling) and implications for the treatment of patients with chronic obstructive pulmonary disease].
Wagena EJ; Huibers MJ; van Schayck CP
Ned Tijdschr Geneeskd; 2001 Aug; 145(31):1492-6. PubMed ID: 11512420
[TBL] [Abstract][Full Text] [Related]
23. [Smoking cessation in smokers with chronic obstructive pulmonary disease].
Underner M; Perriot J; Peiffer G
Rev Mal Respir; 2014 Dec; 31(10):937-60. PubMed ID: 25496790
[TBL] [Abstract][Full Text] [Related]
24. Smoking Cessation in Chronic Obstructive Pulmonary Disease.
Tashkin DP
Semin Respir Crit Care Med; 2015 Aug; 36(4):491-507. PubMed ID: 26238637
[TBL] [Abstract][Full Text] [Related]
25. Australian smokers' use of bupropion and nicotine replacement therapies and their relation to reimbursement, Australia 2001-05.
Lutsenko H; Doran CM; Hall WD
Drug Alcohol Rev; 2008 Mar; 27(2):160-4. PubMed ID: 18264876
[TBL] [Abstract][Full Text] [Related]
26. Smoking cessation interventions in clinical practice.
Cornuz J
Eur J Vasc Endovasc Surg; 2007 Oct; 34(4):397-404. PubMed ID: 17681834
[TBL] [Abstract][Full Text] [Related]
27. Smoking cessation in chronic obstructive pulmonary disease.
Tashkin DP; Murray RP
Respir Med; 2009 Jul; 103(7):963-74. PubMed ID: 19285850
[TBL] [Abstract][Full Text] [Related]
28. Characteristics of patients with COPD in three motivational stages related to smoking cessation.
Hilberink SR; Jacobs JE; Schlösser M; Grol RP; de Vries H
Patient Educ Couns; 2006 Jun; 61(3):449-57. PubMed ID: 16157462
[TBL] [Abstract][Full Text] [Related]
29. Characteristics of COPD smokers and effectiveness and safety of smoking cessation medications.
Jiménez Ruiz CA; Ramos Pinedo A; Cicero Guerrero A; Mayayo Ulibarri M; Cristobal Fernández M; Lopez Gonzalez G
Nicotine Tob Res; 2012 Sep; 14(9):1035-9. PubMed ID: 22345320
[TBL] [Abstract][Full Text] [Related]
30. Lung function and respiratory symptoms in a 1-year randomized smoking cessation trial of varenicline in COPD patients.
Tashkin DP; Rennard S; Taylor Hays J; Lawrence D; Marton JP; Lee TC
Respir Med; 2011 Nov; 105(11):1682-90. PubMed ID: 21621992
[TBL] [Abstract][Full Text] [Related]
31. Ethical analysis of the justifiability of labelling with COPD for smoking cessation.
Kotz D; Vos R; Huibers MJ
J Med Ethics; 2009 Sep; 35(9):534-40. PubMed ID: 19717691
[TBL] [Abstract][Full Text] [Related]
32. Real-life effectiveness of smoking-cessation treatments in general practice clinics in Denmark. The Escape Smoke project.
Poulsen PB; Spillemose H; Nielsen G; Hergel LL; Wedell-Wedellsborg D; Strand M; Ringbæk T
Respir Med; 2015 Feb; 109(2):218-27. PubMed ID: 25592244
[TBL] [Abstract][Full Text] [Related]
33. Cost effectiveness of varenicline versus bupropion and unaided cessation for smoking cessation in a cohort of Finnish adult smokers.
Linden K; Jormanainen V; Linna M; Sintonen H; Wilson K; Kotomäki T
Curr Med Res Opin; 2010 Mar; 26(3):549-60. PubMed ID: 20050814
[TBL] [Abstract][Full Text] [Related]
34. The cost-effectiveness of antidepressants for smoking cessation in chronic obstructive pulmonary disease (COPD) patients.
Van Schayck CP; Kaper J; Wagena EJ; Wouters EF; Severens JL
Addiction; 2009 Dec; 104(12):2110-7. PubMed ID: 19922576
[TBL] [Abstract][Full Text] [Related]
35. Smoking cessation intervention: an evidence-based approach.
Laniado-Laborín R
Postgrad Med; 2010 Mar; 122(2):74-82. PubMed ID: 20203458
[TBL] [Abstract][Full Text] [Related]
36. Smoking cessation interventions in COPD: a network meta-analysis of randomised trials.
Strassmann R; Bausch B; Spaar A; Kleijnen J; Braendli O; Puhan MA
Eur Respir J; 2009 Sep; 34(3):634-40. PubMed ID: 19357145
[TBL] [Abstract][Full Text] [Related]
37. Effectiveness of a stepped primary care smoking cessation intervention: cluster randomized clinical trial (ISTAPS study).
Cabezas C; Advani M; Puente D; Rodriguez-Blanco T; Martin C;
Addiction; 2011 Sep; 106(9):1696-706. PubMed ID: 21561497
[TBL] [Abstract][Full Text] [Related]
38. Primary care providers' views on using lung age as an aid to smoking cessation counseling for patients with chronic obstructive pulmonary disease.
Parker DR; Eltinge S; Rafferty C; Eaton CB; Clarke JG; Goldman RE
Lung; 2015 Jun; 193(3):321-7. PubMed ID: 25791068
[TBL] [Abstract][Full Text] [Related]
39. Combining intensive practice nurse counselling or brief general practitioner advice with varenicline for smoking cessation in primary care: study protocol of a pragmatic randomized controlled trial.
van Rossem C; Spigt M; Smit ES; Viechtbauer W; Mijnheer KK; van Schayck CP; Kotz D
Contemp Clin Trials; 2015 Mar; 41():298-312. PubMed ID: 25657051
[TBL] [Abstract][Full Text] [Related]
40. Lung Cancer: Smoking Cessation.
Latimer KM
FP Essent; 2018 Jan; 464():11-16. PubMed ID: 29313652
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
